[{"Assets_0_Q3_USD":442940000.0,"CommonStockSharesOutstanding_0_Q3_shares":45645000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-122353000.0,"NetIncomeLoss_1_Q3_USD":-58361000.0,"NetIncomeLoss_3_Q3_USD":-150687000.0,"StockholdersEquity_0_Q3_USD":403054000.0,"Ticker":"ATRA","CIK":"1604464","name":"ATARA BIOTHERAPEUTICS, INC.","OfficialName":"Atara Biotherapeutics Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"734540687.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20181106"}]